単一細胞分析市場 – 2030年までの世界予測

この調査レポートでは、単一細胞解析市場を、製品（消耗品[試薬、アッセイキット（免疫アッセイおよび細胞ベースアッセイ）、ビーズ、マイクロプレート、およびその他の消耗品]および機器（PCR機器、NGSシステム、フローサイトメーター、分光光度計、細胞カウンター、顕微鏡、HCSシステム、マイクロアレイ、およびその他の機器）}、細胞の種類（ヒト細胞、動物細胞、微生物細胞）、技術（フローサイトメトリー、次世代シーケンシング、顕微鏡検査、ポリメラーゼ連鎖反応、質量分析、およびその他の技術）、用途（研究用途（がん研究、免疫学研究、神経学研究、幹細胞研究、およびその他の研究用途）および医療用途（非侵襲的出生前診断、体外受精、循環腫瘍細胞検出））およびエンドユーザー（学術機関および研究機関、バイオテクノロジーおよび製薬会社、病院および診断研究所、細胞バンクおよび体外受精センター）、および地域別に分類しています。 （北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカ）本レポートは、シングルセル解析市場の成長に影響を与える主要な要因（推進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要プレーヤーを徹底的に分析し、事業概要、製品、主要戦略、提携、パートナーシップ、契約に関する洞察を提供しています。また、シングルセル解析市場に関連する新製品の発売、提携、買収、最近の動向についても取り上げています。

The single-cell analysis market is projected to reach USD 7.56 billion by 2030 from an estimated USD 3.81 billion in 2025, at a CAGR of 14.7% during the forecast period.

単一細胞分析市場は、予測期間中に14.7%のCAGRで成長し、2025年の推定38億1,000万米ドルから2030年までに75億6,000万米ドルに達すると予測されています。

This market growth is largely driven by the increasing emphasis on personalized medicine. Rising research & development investments in the pharmaceutical and biotechnology industries also contribute to the expansion of single-cell analysis. Additionally, factors such as growth in stem cell research and advancements in single-cell analysis technologies are expected to further boost the market. Furthermore, the increasing incidence of cancer is creating a demand for advanced therapies, which is anticipated to enhance the growth of the single-cell analysis market. The rising adoption of advanced single-cell sequencing techniques is also expected to propel market growth in the coming years.

この市場の成長は、パーソナライズ医療への関心の高まりに大きく牽引されています。製薬業界およびバイオテクノロジー業界における研究開発投資の増加も、シングルセル解析の拡大に貢献しています。さらに、幹細胞研究の発展やシングルセル解析技術の進歩といった要因も、市場をさらに押し上げると予想されます。さらに、がんの発生率増加は高度な治療法への需要を生み出しており、シングルセル解析市場の成長を促進すると予想されます。高度なシングルセルシーケンシング技術の採用増加も、今後数年間の市場成長を牽引すると予想されます。

“The research applications segment accounted for the largest share of the market segment in 2024.”

The single-cell analysis market is divided into two main categories based on applications: research and medical applications. The research application segment includes various fields such as cancer research, immunology research, neurology research, stem cell research, and other related areas. In contrast, the medical applications segment is further divided into non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumor cell detection.

In 2024, the research applications segment held the largest share of the global single-cell analysis market. The increasing prevalence of cancer is driving the demand for advanced therapies, which contributes to the growth of this segment. Additionally, the expansion of stem cell research is also expected to further boost the growth of the single-cell analysis market.

“The flow cytometry segment accounted for a major share of the market in 2024.”

The single-cell analysis market is categorized based on technology into several segments: flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. In 2024, the flow cytometry segment was the largest contributor to the global single-cell analysis market by technology. This significant growth is primarily due to the widespread use of flow cytometry in single-cell analysis, as it can perform multiple measurements within a heterogeneous mixture. Furthermore, the increasing adoption of advanced cell identification and characterization technologies is expected to further drive growth in this segment of the single-cell analysis market.

“The US dominated the single-cell analysis market in 2024.”

The single-cell analysis market is divided into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, the US dominated this market in North America. As the world’s largest biopharmaceutical market, the US leads in biopharmaceutical research and investments. Its robust healthcare infrastructure further supports research & development in the life sciences sector. Additionally, the presence of numerous biopharmaceutical companies and increasing research activities in the biotechnology industry are contributing to market growth in the US. Furthermore, the rising focus on developing personalized medicine, driven by the increasing incidence of cancer, is also boosting the growth of the single-cell analysis market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side (70%) and Demand Side (30%)
• By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
• By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and Middle East & Africa (5%)

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• BD (US)
• Agilent Technologies, Inc. (US)
• QIAGEN (Netherlands)
• 10x Genomics (US)
• Illumina, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• DiaSorin S.p.A. (Italy)
• Standard BioTools (US)
• Tecan Trading AG (Switzerland)
• Sartorius AG (Germany)
• Corning Incorporated (US)
• Cytek Biosciences (US)
• Takara Bio Inc. (Japan)
• bioMérieux (France)
• Revvity (US)
• Bio-Techne (US)
• PacBio (US)
• Bruker (US)
• Promega Corporation (US)
• Oxford Nanopore Technologies plc. (UK)
• The Menarini Group (Italy)
• Singleron Biotechnologies (Germany)
• BICO (Sweden)
• Fluent BioSciences (US)
• RareCyte, Inc. (US)
• Cell Microsystems (US)
• NanoCellect Biomedical (US)
• Apogee Flow Systems Ltd. (UK)
• Creative Biolabs (US)
• Sphere Bio (UK)
• Yokogawa Electric Corporation (Japan)

Research Coverage:

This research report categorizes the single-cell analysis market by product {consumables [reagents, assay kits (immunoassays and cell-based assays), beads, microplates, and other consumables] and instruments (PCR instruments, NGS systems, flow cytometers, spectrophotometers, cell counters, microscopes, HCS systems, microarrays, and other instruments)}, cell type (human cells, animal cells, and microbial cells), technique (flow cytometry, next-generation sequencing, microscopy, polymerase chain reaction, mass spectrometry, and other techniques), application [research applications (cancer research, immunology research, neurology research, stem cell research, and other research applications) and medical applications (non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumour cell detection)], end user (academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-cell analysis market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations, acquisitions, and recent developments associated with the single-cell analysis market.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing the closest approximations of the revenue numbers for the overall single-cell analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (technological advancements in single-cell analysis products, the surge in cases of cancer, and increasing R&D in pharmaceutical & biotechnology industries for complex diseases), restraints (high cost of single-cell analysis products), opportunities (integration of microfluidics in single-cell analysis), and challenges (standardization of protocols and data integration & quality control for developing cell therapies) influencing the growth of the market
• Product Development/Innovation: Detailed insights on newly launched products of the single-cell analysis market
• Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-cell analysis market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), BD (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), 10x Genomics (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), DiaSorin S.p.A. (Italy), Standard BioTools (US), Tecan Trading AG (Switzerland), Sartorius AG (Germany), Corning Incorporated (US), Cytek Biosciences (US), Takara Bio Inc. (Japan), bioMérieux (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies plc. (UK), The Menarini Group (Italy), Singleron Biotechnologies (Germany), BICO (Sweden), Fluent BioSciences (US), RareCyte, Inc. (US), Cell Microsystems (US), NanoCellect Biomedical (US), Apogee Flow Systems Ltd. (UK), Creative Biolabs (US) Sphere Bio (UK), and Yokogawa Electric Corporation (Japan)

Table of Contents

1               INTRODUCTION              47

1.1           STUDY OBJECTIVES       47

1.2           MARKET DEFINITION   47

1.3           STUDY SCOPE   47

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 48

1.3.2        YEARS CONSIDERED      49

1.3.3        INCLUSIONS AND EXCLUSIONS 49

1.4           CURRENCY CONSIDERED            50

1.5           STAKEHOLDERS               51

1.6           SUMMARY OF CHANGES               51

2               RESEARCH METHODOLOGY       52

2.1           RESEARCH DATA              52

2.1.1        SECONDARY DATA          53

2.1.2        PRIMARY DATA 53

2.2           MARKET SIZE ESTIMATION METHODOLOGY     55

2.2.1        GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION     55

2.2.2        INSIGHTS FROM PRIMARY EXPERTS        57

2.2.3        TOP-DOWN APPROACH                58

2.3           MARKET GROWTH RATE PROJECTIONS                59

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 61

2.5           RESEARCH ASSUMPTIONS           62

2.6           RISK ANALYSIS  62

2.7           RESEARCH LIMITATIONS             62

3               EXECUTIVE SUMMARY  64

4               PREMIUM INSIGHTS       68

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SINGLE-CELL ANALYSIS MARKET             68

4.2           NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE AND COUNTRY          69

4.3          SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030        69

4.4           SINGLE-CELL ANALYSIS MARKET, BY END USER                 70

4.5           SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES         70

5               MARKET OVERVIEW       71

5.1           INTRODUCTION              71

5.2           MARKET DYNAMICS       71

5.2.1        DRIVERS               73

5.2.1.1    Technological advancements in single-cell analysis products                 73

5.2.1.2    Rising prevalence of cancer 74

5.2.1.3    Increasing R&D in pharmaceutical and biotechnology industries                 75

5.2.1.4    Growth in stem cell research               76

5.2.1.5    Growing focus on personalized medicine         78

5.2.2        RESTRAINTS      79

5.2.2.1    High cost of single-cell analysis products         79

5.2.3        OPPORTUNITIES              80

5.2.3.1    High growth potential of single-cell sequencing              80

5.2.3.2    Integration of microfluidics in single-cell analysis          80

5.2.3.3    Rising potential in emerging Asian markets     81

5.2.4        CHALLENGES    81

5.2.4.1    Lack of standardization in protocols and quality control procedures             81

5.2.4.2    Technical limitations of single-cell analysis     82

5.2.4.3    Mounting ethical and privacy concerns             82

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            82

5.4           VALUE CHAIN ANALYSIS               83

5.5           ECOSYSTEM ANALYSIS  85

5.6           TECHNOLOGY ANALYSIS             88

5.6.1        KEY TECHNOLOGIES     88

5.6.1.1    Flow cytometry     88

5.6.1.2    Next-generation sequencing               88

5.6.1.3    Polymerase chain reaction  89

5.6.1.4    Microscopy            89

5.6.1.5    Mass spectrometry                90

5.6.2        COMPLEMENTARY TECHNOLOGIES       90

5.6.2.1    Bioinformatics tools and computational analysis             90

5.6.2.2    Multi-omics integration       91

5.6.3        ADJACENT TECHNOLOGIES       92

5.6.3.1    Nanotechnology    92

5.6.3.2    Artificial intelligence and machine learning     92

5.7           PATENT ANALYSIS          92

5.7.1        METHODOLOGY              92

5.7.2        PATENTS APPLIED AND GRANTED, 2014–2024    92

5.8           TRADE ANALYSIS             95

5.8.1        IMPORT DATA (HS CODE 9027) 95

5.8.2        EXPORT DATA (HS CODE 9027) 97

5.9           PORTER’S FIVE FORCES ANALYSIS           99

5.9.1        THREAT OF NEW ENTRANTS      100

5.9.2        THREAT OF SUBSTITUTES          100

5.9.3        BARGAINING POWER OF SUPPLIERS       100

5.9.4        BARGAINING POWER OF BUYERS             100

5.9.5        INTENSITY OF COMPETITIVE RIVALRY 101

5.10         TARIFF & REGULATORY LANDSCAPE     101

5.10.1      TARIFF DATA (HS CODE 9027)    101

5.10.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             102

5.10.3      REGULATORY FRAMEWORK       105

5.11         PRICING ANALYSIS          108

5.11.1      AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS     108

5.11.2      AVERAGE SELLING PRICE OF PRODUCTS, BY REGION                 108

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        109

5.13         KEY STAKEHOLDERS AND BUYING CRITERIA     110

5.13.1      KEY STAKEHOLDERS IN BUYING PROCESS           110

5.13.2      ROLE OF STAKEHOLDERS IN BUYING PROCESS 110

5.13.3      BUYING CRITERIA           111

5.14         INVESTMENT AND FUNDING SCENARIO               112

5.15         IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET               113

5.15.1      AI USE-CASES    114

5.15.2      KEY COMPANIES IMPLEMENTING AI      115

5.16         CASE STUDY ANALYSIS 115

5.16.1      COMPREHENSIVE SINGLE‑CELL TRANSCRIPTOMIC ATLAS OF HUMAN CORNEA        115

5.16.2      MASSIVELY PARALLEL SINGLE-CELL RNA SEQUENCING IDENTIFIES RARE DRUG-RESISTANT CANCER SUBPOPULATIONS         115

5.16.3      SINGLE-CELL ANALYSIS OF RENAL CELL CARCINOMA REVEALS TUMOR HETEROGENEITY AND MICROENVIRONMENTAL COMPLEXITY                116

5.17         US 2025 TARIFF IMPACT OVERVIEW        116

5.17.1      INTRODUCTION              116

5.17.2      KEY TARIFF RATES          117

5.17.3      PRICE IMPACT ANALYSIS             118

5.17.4      KEY IMPACT ON VARIOUS REGIONS       119

5.17.4.1  US           119

5.17.4.2  Europe   119

5.17.4.3  Asia Pacific            119

5.17.4.4  Rest of the World 120

5.17.5      END-USE INDUSTRY IMPACT     120

5.17.5.1  Pharmaceutical and biotech companies            120

5.17.5.2  Contract research organizations (CROs)         120

5.17.5.3  Academic & research institutes          121

6               SINGLE-CELL ANALYSIS MARKET, BY APPLICATION                 122

6.1           INTRODUCTION              123

6.2           RESEARCH APPLICATIONS          123

6.2.1        CANCER RESEARCH        127

6.2.1.1    Rising prevalence of cancer to drive market     127

6.2.2        IMMUNOLOGY RESEARCH           130

6.2.2.1    High incidence of immunological disorders to propel market                 130

6.2.3        NEUROLOGY RESEARCH               133

6.2.3.1    Increasing incidence of neurological disorders to boost market                 133

6.2.4        STEM CELL RESEARCH  136

6.2.4.1    Rising investments in stem cell research to drive market                 136

6.2.5        OTHER RESEARCH APPLICATIONS          139

6.3           MEDICAL APPLICATIONS             142

6.3.1        NON-INVASIVE PRENATAL DIAGNOSIS 145

6.3.1.1    Increasing prevalence of genetic diseases to drive demand                 145

6.3.2        IN VITRO FERTILIZATION            149

6.3.2.1    Growing demand for IVF procedures to support market                 149

6.3.3        CIRCULATING TUMOR CELL DETECTION            152

6.3.3.1    Rising prevalence of cancer to contribute to segment growth                 152

7               SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE                 155

7.1           INTRODUCTION              156

7.2           HUMAN CELLS  156

7.2.1        GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND             156

7.3           ANIMAL CELLS  159

7.3.1        INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET               159

7.4           MICROBIAL CELLS           162

7.4.1        RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET        162

8               SINGLE-CELL ANALYSIS MARKET, BY END USER                 166

8.1           INTRODUCTION              167

8.2           ACADEMIC & RESEARCH LABORATORIES             167

8.2.1        INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET         167

8.3           BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES                 171

8.3.1        GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET        171

8.4           HOSPITALS & DIAGNOSTIC LABORATORIES       174

8.4.1        HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND   174

8.5           CELL BANKS & IVF CENTERS       178

8.5.1        RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET              178

9               SINGLE-CELL ANALYSIS MARKET, BY PRODUCT                 182

9.1           INTRODUCTION              183

9.2           CONSUMABLES 183

9.2.1        BEADS  186

9.2.1.1    Increasing use in research and genetic exploration to drive market                 186

9.2.2        MICROPLATES  189

9.2.2.1    Rising frequency of product launches to boost market   189

9.2.3        REAGENTS          192

9.2.3.1    Advancements in single-cell genomics to increase demand                 192

9.2.4        ASSAY KITS         195

9.2.4.1    Immunoassays      198

9.2.4.1.1 Growth in geriatric population to fuel demand                198

9.2.4.2    Cell-based assays  200

9.2.4.2.1 Increasing use in pharma and biopharma companies to drive market    200

9.2.5        OTHER CONSUMABLES 203

9.3           INSTRUMENTS 206

9.3.1        FLOW CYTOMETERS      209

9.3.1.1    Technological advancements to drive demand                 209

9.3.2        NGS SYSTEMS    213

9.3.2.1    Increased affordability to support segment growth         213

9.3.3        PCR INSTRUMENTS        216

9.3.3.1    Rising use for DNA and mRNA amplification to boost market                 216

9.3.4        SPECTROPHOTOMETERS             218

9.3.4.1    Technological advancements to boost market 218

9.3.5        CELL COUNTERS              221

9.3.5.1    Rising demand for automated cell counters to fuel market                 221

9.3.6        MICROSCOPES  224

9.3.6.1    Increasing use in cell-based research to drive market    224

9.3.7        HCS SYSTEMS    227

9.3.7.1    Growing need for multi-parametric cell analysis to drive adoption                 227

9.3.8        MICROARRAYS  229

9.3.8.1    Increasing development of targeted therapies to support market                 229

9.3.9        OTHER INSTRUMENTS 232

10            SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE                 236

10.1         INTRODUCTION              237

10.2         FLOW CYTOMETRY         237

10.2.1      INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET 237

10.3         NEXT-GENERATION SEQUENCING          241

10.3.1      WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET               241

10.4         POLYMERASE CHAIN REACTION               244

10.4.1      INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET          244

10.5         MICROSCOPY    247

10.5.1      FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET  247

10.6         MASS SPECTROMETRY  250

10.6.1      LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET                 250

10.7         OTHER TECHNIQUES    253

11            SINGLE-CELL ANALYSIS MARKET, BY REGION    257

11.1         INTRODUCTION              258

11.2         NORTH AMERICA             258

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 263

11.2.2      US           264

11.2.2.1  Increasing R&D investments and funding to drive market                 264

11.2.3      CANADA               269

11.2.3.1  High prevalence of hemophilia to propel market             269

11.3         EUROPE               273

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      277

11.3.2      GERMANY           278

11.3.2.1  Growing awareness of advanced cell therapies to support market                 278

11.3.3      UK          282

11.3.3.1  Growing adoption of single-cell analysis products to drive demand  282

11.3.4      FRANCE                286

11.3.4.1  Growing government funding for R&D to propel market                 286

11.3.5      ITALY    290

11.3.5.1  Focus on cell biology research to drive market                 290

11.3.6      SPAIN    294

11.3.6.1  Increasing number of biotechnology companies to drive demand                 294

11.3.7      REST OF EUROPE             298

11.4         ASIA PACIFIC     303

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 308

11.4.2      CHINA  309

11.4.2.1  Increasing R&D expenditure to support market              309

11.4.3      JAPAN   313

11.4.3.1  Increasing geriatric population to fuel demand               313

11.4.4      INDIA    317

11.4.4.1  Growing focus on development of cell-based therapies to boost market    317

11.4.5      SOUTH KOREA  321

11.4.5.1  Increasing number of strategic alliances to boost market                 321

11.4.6      AUSTRALIA         325

11.4.6.1  Rising number of life science companies to boost demand                 325

11.4.7      REST OF ASIA PACIFIC   329

11.5         LATIN AMERICA                333

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 337

11.5.2      BRAZIL 338

11.5.2.1  Rising focus on biotechnology industry to bolster market                 338

11.5.3      MEXICO                342

11.5.3.1  Government support for biopharmaceutical production to drive market    342

11.5.4      REST OF LATIN AMERICA             346

11.6         MIDDLE EAST   350

11.6.1      MACROECONOMIC OUTLOOK IN MIDDLE EAST                 354

11.6.2      GCC       355

11.6.2.1  Saudi Arabia          359

11.6.2.1.1                Increasing healthcare expenditure to drive market                 359

11.6.2.2  United Arab Emirates          363

11.6.2.2.1                Advancements in biopharmaceutical sector to drive demand  363

11.6.2.3  Rest of GCC          367

11.6.3      REST OF MIDDLE EAST 371

11.7         AFRICA 375

11.7.1      GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET                 375

11.7.2      MACROECONOMIC OUTLOOK FOR AFRICA        379

12            COMPETITIVE LANDSCAPE         381

12.1         OVERVIEW          381

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025                 381

12.3         REVENUE ANALYSIS, 2022–2024  386

12.4         MARKET SHARE ANALYSIS, 2024                 387

12.4.1      RANKING OF KEY MARKET PLAYERS       389

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 389

12.5.1      STARS   389

12.5.2      EMERGING LEADERS     389

12.5.3      PERVASIVE PLAYERS      390

12.5.4      PARTICIPANTS 390

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         391

12.5.5.1  Company footprint               391

12.5.5.2  Product footprint  392

12.5.5.3  Region footprint   393

12.5.5.4  Technique footprint             394

12.5.5.5  Application footprint            395

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        396

12.6.1      PROGRESSIVE COMPANIES         396

12.6.2      RESPONSIVE COMPANIES            396

12.6.3      DYNAMIC COMPANIES  396

12.6.4      STARTING BLOCKS         396

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 398

12.6.5.1  Detailed list of key startups/SMEs    398

12.6.5.2  Competitive benchmarking of key startups/SMEs          399

12.7         COMPANY VALUATION AND FINANCIAL METRICS                 400

12.8         BRAND/PRODUCT COMPARISON             401

12.9         COMPETITIVE SCENARIO             403

12.9.1      PRODUCT LAUNCHES   403

12.9.2      DEALS  405

12.9.3      EXPANSIONS     407

13            COMPANY PROFILES      408

13.1         INTRODUCTION              408

13.2         KEY PLAYERS     408

13.2.1      BD          408

13.2.1.1  Business overview 408

13.2.1.2  Products offered   409

13.2.1.3  Recent developments           411

13.2.1.3.1                Product launches  411

13.2.1.3.2                Deals      412

13.2.1.4  MnM view              412

13.2.1.4.1                Key strengths        412

13.2.1.4.2                Strategic choices   413

13.2.1.4.3                Weaknesses and competitive threats 413

13.2.2      THERMO FISHER SCIENTIFIC INC.            414

13.2.2.1  Business overview 414

13.2.2.2  Products offered   415

13.2.2.3  Recent developments           418

13.2.2.3.1                Product launches  418

13.2.2.3.2                Deals      418

13.2.2.4  MnM view              419

13.2.2.4.1                Key strengths        419

13.2.2.4.2                Strategic choices   419

13.2.2.4.3                Weaknesses and competitive threats 419

13.2.3      DANAHER CORPORATION           420

13.2.3.1  Business overview 420

13.2.3.2  Products offered   421

13.2.3.3  Recent developments           423

13.2.3.3.1                Deals      423

13.2.3.4  MnM view              424

13.2.3.4.1                Key strengths        424

13.2.3.4.2                Strategic choices   424

13.2.3.4.3                Weaknesses and competitive threats 424

13.2.4      10X GENOMICS 425

13.2.4.1  Business overview 425

13.2.4.2  Products offered   427

13.2.4.3  Recent developments           428

13.2.4.3.1                Product launches  428

13.2.4.3.2                Deals      429

13.2.5      MERCK KGAA    431

13.2.5.1  Business overview 431

13.2.5.2  Products offered   432

13.2.5.3  Recent developments           434

13.2.5.3.1                Deals      434

13.2.6      AGILENT TECHNOLOGIES, INC.                435

13.2.6.1  Business overview 435

13.2.6.2  Products offered   436

13.2.6.3  Recent developments           438

13.2.6.3.1                Product launches  438

13.2.6.3.2                Deals      439

13.2.7      QIAGEN                440

13.2.7.1  Business overview 440

13.2.7.2  Products offered   442

13.2.7.3  Recent developments           443

13.2.7.3.1                Deals      443

13.2.8      ILLUMINA, INC. 444

13.2.8.1  Business overview 444

13.2.8.2  Products offered   445

13.2.8.3  Recent developments           447

13.2.8.3.1                Product launches  447

13.2.8.3.2                Deals      447

13.2.9      BIO-RAD LABORATORIES, INC.  449

13.2.9.1  Business overview 449

13.2.9.2  Products offered   451

13.2.9.3  Recent developments           453

13.2.9.3.1                Product launches  453

13.2.10   DIASORIN S.P.A.                454

13.2.10.1                 Business overview 454

13.2.10.2                 Products offered   456

13.2.10.3                 Recent developments           456

13.2.10.3.1             Deals      456

13.2.11   STANDARD BIOTOOLS 457

13.2.11.1                 Business overview 457

13.2.11.2                 Product offered     458

13.2.11.3                 Recent developments           459

13.2.11.3.1             Product launches  459

13.2.11.3.2             Deals      460

13.2.12   TECAN TRADING AG      461

13.2.12.1                 Business overview 461

13.2.12.2                 Products offered   462

13.2.12.3                 Recent developments           463

13.2.12.3.1             Product launches  463

13.2.12.3.2             Deals      463

13.2.13   SARTORIUS AG 464

13.2.13.1                 Business overview 464

13.2.13.2                 Products offered   465

13.2.13.3                 Recent developments           466

13.2.13.3.1             Deals      466

13.2.13.3.2             Expansions             466

13.2.14   CORNING INCORPORATED         467

13.2.14.1                 Business overview 467

13.2.14.2                 Products offered   468

13.2.15   CYTEK BIOSCIENCES     469

13.2.15.1                 Business overview 469

13.2.15.2                 Products offered   470

13.2.15.3                 Recent developments           470

13.2.15.3.1             Product launches  470

13.2.15.3.2             Deals      471

13.2.15.3.3             Expansions             471

13.2.16   TAKARA BIO INC.             472

13.2.16.1                 Business overview 472

13.2.16.2                 Products offered   473

13.2.16.3                 Recent developments           475

13.2.16.3.1             Product launches  475

13.2.16.3.2             Deals      475

13.2.17   BIOMÉRIEUX     476

13.2.17.1                 Business overview 476

13.2.17.2                 Products offered   477

13.2.17.3                 Recent developments           478

13.2.17.3.1             Deals      478

13.2.18   REVVITY               479

13.2.18.1                 Business overview 479

13.2.18.2                 Products offered   480

13.2.18.3                 Recent developments           482

13.2.18.3.1             Deals      482

13.2.19   BIO-TECHNE     483

13.2.19.1                 Business overview 483

13.2.19.2                 Products offered   484

13.2.19.3                 Recent developments           485

13.2.19.3.1             Deals      485

13.2.20   PACBIO 486

13.2.20.1                 Business overview 486

13.2.20.2                 Products offered   487

13.2.20.3                 Recent developments           487

13.2.20.3.1             Product launches  487

13.2.21   BRUKER                488

13.2.21.1                 Business overview 488

13.2.21.2                 Products offered   490

13.2.21.3                 Recent developments           491

13.2.21.3.1             Product launches  491

13.2.21.3.2             Deals      492

13.2.22   PROMEGA CORPORATION           493

13.2.22.1                 Business overview 493

13.2.22.2                 Products offered   493

13.2.23   OXFORD NANOPORE TECHNOLOGIES PLC          495

13.2.23.1                 Business overview 495

13.2.23.2                 Products offered   496

13.2.23.3                 Recent developments           497

13.2.23.3.1             Deals      497

13.3         OTHER PLAYERS              498

13.3.1      SINGLERON BIOTECHNOLOGIES             498

13.3.2      CELL MICROSYSTEMS   499

13.3.3      NANOCELLECT BIOMEDICAL    500

13.3.4      RARECYTE, INC.                501

13.3.5      BICO      502

13.3.6      MENARINI GROUP           503

13.3.7      APOGEE FLOW SYSTEMS LTD    504

13.3.8      CREATIVE BIOLABS        505

13.3.9      SPHERE BIO       506

13.3.10   YOKOGAWA ELECTRIC CORPORATION 507

14            APPENDIX           508

14.1         DISCUSSION GUIDE        508

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                514

14.3         CUSTOMIZATION OPTIONS        516

14.4         RELATED REPORTS         516

14.5         AUTHOR DETAILS           517

LIST OF TABLES

TABLE 1                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              60

TABLE 2                SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS            72

TABLE 3                RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES         73

TABLE 4                PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS,

2015 VS. 2018 VS. 2020 VS. 2035     74

TABLE 5                PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)                76

TABLE 6                ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019–2025          77

TABLE 7                SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS     85

TABLE 8                SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS            86

TABLE 9                SINGLE-CELL ANALYSIS MARKET: END USERS                 87

TABLE 10              SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES  87

TABLE 11              APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS          89

TABLE 12              TYPES OF BIOINFORMATICS TOOLS       91

TABLE 13              PATENTS FILED, 2014–2024           92

TABLE 14              INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024              94

TABLE 15              IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)            95

TABLE 16              IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (TONS)  96

TABLE 17              EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)            97

TABLE 18              EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (TONS)  98

TABLE 19              SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 100

TABLE 20              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  102

TABLE 21              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  102

TABLE 22              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  103

TABLE 23              ROW: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 104

TABLE 24              SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES        105

TABLE 25              AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022–2024                 108

TABLE 26              AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024     108

TABLE 27              SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 109

TABLE 28              BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER            111

TABLE 29              US ADJUSTED RECIPROCAL TARIFF RATES                 117

TABLE 30              KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS AND ELECTRICAL MACHINERY AND EQUIPMENT AND PARTS THEREOF    118

TABLE 31              CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES            118

TABLE 32              SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              123

TABLE 33              SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            124

TABLE 34              SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)            124

TABLE 35              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       124

TABLE 36              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)             125

TABLE 37              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)             125

TABLE 38              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       126

TABLE 39              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               126

TABLE 40              GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               126

TABLE 41              SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION,

2023–2030 (USD MILLION)            127

TABLE 42              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               127

TABLE 43              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)                 128

TABLE 44              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               128

TABLE 45              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)             129

TABLE 46              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               129

TABLE 47              GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)                 129

TABLE 48              SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION)            130

TABLE 49              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)       131

TABLE 50              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               131

TABLE 51              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               131

TABLE 52              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)       132

TABLE 53              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               132

TABLE 54              GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               132

TABLE 55              SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION,

2023–2030 (USD MILLION)            133

TABLE 56              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 134

TABLE 57              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               134

TABLE 58              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               134

TABLE 59              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               135

TABLE 60              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               135

TABLE 61              GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)            135

TABLE 62              SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION,

2023–2030 (USD MILLION)            136

TABLE 63              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               136

TABLE 64              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 65              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 66              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               138

TABLE 67              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               138

TABLE 68              GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)                 138

TABLE 69              SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS,

BY REGION, 2023–2030 (USD MILLION)   139

TABLE 70              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            139

TABLE 71              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 140

TABLE 72              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 140

TABLE 73              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            141

TABLE 74              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 141

TABLE 75              GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               141

TABLE 76              SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            142

TABLE 77              SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            142

TABLE 78              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       143

TABLE 79              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               143

TABLE 80              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               144

TABLE 81              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               144

TABLE 82              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               144

TABLE 83              GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            145

TABLE 84              SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS,

BY REGION, 2023–2030 (USD MILLION)   146

TABLE 85              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)     146

TABLE 86              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 147

TABLE 87              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)       147

TABLE 88              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)     148

TABLE 89              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)       148

TABLE 90              GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 148

TABLE 91              SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION,

2023–2030 (USD MILLION)            149

TABLE 92              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)       149

TABLE 93              EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,

BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 94              ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,

BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 95              LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 96              MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 97              GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)                 151

TABLE 98              SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION,

BY REGION, 2023–2030 (USD MILLION)   152

TABLE 99              NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)     152

TABLE 100            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)       153

TABLE 101            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)            153

TABLE 102            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)     154

TABLE 103            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)            154

TABLE 104            GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)       154

TABLE 105          SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)            156

TABLE 106            SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION,

2023–2030 (USD MILLION)            157

TABLE 107            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               157

TABLE 108            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)                 158

TABLE 109            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)                 158

TABLE 110            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               158

TABLE 111            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)                 159

TABLE 112            GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY,

2023–2030 (USD MILLION)            159

TABLE 113            SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION,

2023–2030 (USD MILLION)            160

TABLE 114            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               160

TABLE 115            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)                 161

TABLE 116            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               161

TABLE 117            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               161

TABLE 118            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)                 162

TABLE 119            GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY,

2023–2030 (USD MILLION)            162

TABLE 120            SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION,

2023–2030 (USD MILLION)            163

TABLE 121            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               163

TABLE 122            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)                 164

TABLE 123            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               164

TABLE 124            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               164

TABLE 125            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,

BY COUNTRY, 2023–2030 (USD MILLION)               165

TABLE 126            GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)                 165

TABLE 127            SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)            167

TABLE 128            SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES,

BY REGION, 2023–2030 (USD MILLION)   168

TABLE 129            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     168

TABLE 130            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)       169

TABLE 131            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            169

TABLE 132            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     170

TABLE 133            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            170

TABLE 134            GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)       170

TABLE 135            SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)          171

TABLE 136            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   172

TABLE 137            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     172

TABLE 138            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     173

TABLE 139            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   173

TABLE 140            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     173

TABLE 141            GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     174

TABLE 142            SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)       175

TABLE 143            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     175

TABLE 144            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            176

TABLE 145            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            176

TABLE 146            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     177

TABLE 147            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            177

TABLE 148            GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            177

TABLE 149            SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2023–2030 (USD MILLION)                 178

TABLE 150            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)       179

TABLE 151            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 152            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)            180

TABLE 153            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)       180

TABLE 154            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)            180

TABLE 155            GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               181

TABLE 156            SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            183

TABLE 157            SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            183

TABLE 158            SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION,

2023–2030 (USD MILLION)            184

TABLE 159            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               184

TABLE 160            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)                 184

TABLE 161            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)                 185

TABLE 162            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               185

TABLE 163            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               185

TABLE 164            GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY,

2023–2030 (USD MILLION)            186

TABLE 165            SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION,

2023–2030 (USD MILLION)            187

TABLE 166            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)                 187

TABLE 167            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,

2023–2030 (USD MILLION)            187

TABLE 168            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 169            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)                 188

TABLE 170            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 171            GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 172            SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION,

2023–2030 (USD MILLION)            190

TABLE 173            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES,

BY COUNTRY, 2023–2030 (USD MILLION)               190

TABLE 174            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)                 190

TABLE 175            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)                 191

TABLE 176            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES,

BY COUNTRY, 2023–2030 (USD MILLION)               191

TABLE 177            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)                 191

TABLE 178            GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY,

2023–2030 (USD MILLION)            192

TABLE 179            SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION,

2023–2030 (USD MILLION)            192

TABLE 180            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)            193

TABLE 181            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY,

2023–2030 (USD MILLION)            193

TABLE 182            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 193

TABLE 183            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)            194

TABLE 184            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 194

TABLE 185            GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY,

2023–2030 (USD MILLION)            194

TABLE 186            SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            195

TABLE 187            SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION,

2023–2030 (USD MILLION)            195

TABLE 188            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)            196

TABLE 189            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY,

2023–2030 (USD MILLION)            196

TABLE 190            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)                 196

TABLE 191            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)            197

TABLE 192            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)                 197

TABLE 193            GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY,

2023–2030 (USD MILLION)            197

TABLE 194            SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2023–2030 (USD MILLION)                 198

TABLE 195            NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)       198

TABLE 196            EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               199

TABLE 197            ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 199

TABLE 198            LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 199

TABLE 199            MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 200

TABLE 200            GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               200

TABLE 201            SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS,

BY REGION, 2023–2030 (USD MILLION)   201

TABLE 202            NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)            201

TABLE 203            EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 201

TABLE 204            ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)       202

TABLE 205            LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)       202

TABLE 206            MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)       202

TABLE 207            GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 208            SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION,

2023–2030 (USD MILLION)            203

TABLE 209            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 210            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 211            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 212            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               205

TABLE 213            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               205

TABLE 214            GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)            205

TABLE 215            SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            206

TABLE 216            SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION,

2023–2030 (USD MILLION)            207

TABLE 217            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               207

TABLE 218            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 207

TABLE 219            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 208

TABLE 220            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               208

TABLE 221            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 208

TABLE 222            GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY,

2023–2030 (USD MILLION)            209

TABLE 223            SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY REGION,

2023–2030 (USD MILLION)            210

TABLE 224            NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 225            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)                 211

TABLE 226            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 227            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 228            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 229            GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)                 212

TABLE 230            SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            213

TABLE 231            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 232            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)                 214

TABLE 233            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)                 214

TABLE 234            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               215

TABLE 235            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)                 215

TABLE 236            GCC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY,

2023–2030 (USD MILLION)            215

TABLE 237            SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY REGION,

2023–2030 (USD MILLION)            216

TABLE 238            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               216

TABLE 239            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 217

TABLE 240            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               217

TABLE 241            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               217

TABLE 242            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               218

TABLE 243            GCC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 218

TABLE 244            SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY REGION, 2023–2030 (USD MILLION)            219

TABLE 245            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)       219

TABLE 246            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 247            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS,

BY COUNTRY, 2023–2030 (USD MILLION)               220

TABLE 248            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)       220

TABLE 249            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS,

BY COUNTRY, 2023–2030 (USD MILLION)               220

TABLE 250            GCC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)            221

TABLE 251            SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY REGION,

2023–2030 (USD MILLION)            222

TABLE 252            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 253            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)                 222

TABLE 254            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               223

TABLE 255            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               223

TABLE 256            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               223

TABLE 257            GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY,

2023–2030 (USD MILLION)            224

TABLE 258            SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY REGION,

2023–2030 (USD MILLION)            224

TABLE 259            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES,

BY COUNTRY, 2023–2030 (USD MILLION)               225

TABLE 260            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)                 225

TABLE 261            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)                 225

TABLE 262            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES,

BY COUNTRY, 2023–2030 (USD MILLION)               226

TABLE 263            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)                 226

TABLE 264            GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY,

2023–2030 (USD MILLION)            226

TABLE 265            SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            227

TABLE 266            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               227

TABLE 267            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 228

TABLE 268            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)                 228

TABLE 269            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               228

TABLE 270            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)                 229

TABLE 271            GCC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY,

2023–2030 (USD MILLION)            229

TABLE 272            SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY REGION,

2023–2030 (USD MILLION)            230

TABLE 273            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               230

TABLE 274            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)                 231

TABLE 275            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)                 231

TABLE 276            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               231

TABLE 277            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 278            GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY,

2023–2030 (USD MILLION)            232

TABLE 279            SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION,

2023–2030 (USD MILLION)            233

TABLE 280            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 281            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 282            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 283            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 284            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 285            GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)                 235

TABLE 286            SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 237

TABLE 287            SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION,

2023–2030 (USD MILLION)            238

TABLE 288            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               238

TABLE 289            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 290            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 291            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               240

TABLE 292            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               240

TABLE 293            GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)                 240

TABLE 294            SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING,

BY REGION, 2023–2030 (USD MILLION)   241

TABLE 295            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)            242

TABLE 296            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 242

TABLE 297            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)       243

TABLE 298            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)            243

TABLE 299            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)       243

TABLE 300            GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING,

BY COUNTRY, 2023–2030 (USD MILLION)               244

TABLE 301            SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION)            245

TABLE 302            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)            245

TABLE 303            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION,

BY COUNTRY, 2023–2030 (USD MILLION)               245

TABLE 304            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 246

TABLE 305            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)            246

TABLE 306            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 246

TABLE 307            GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION,

BY COUNTRY, 2023–2030 (USD MILLION)               247

TABLE 308            SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION,

2023–2030 (USD MILLION)            247

TABLE 309            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY,

BY COUNTRY, 2023–2030 (USD MILLION)               248

TABLE 310            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 248

TABLE 311            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)                 248

TABLE 312            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)            249

TABLE 313            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)                 249

TABLE 314            GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY,

2023–2030 (USD MILLION)            249

TABLE 315            SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION,

2023–2030 (USD MILLION)            250

TABLE 316            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)             250

TABLE 317            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               251

TABLE 318            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)             251

TABLE 319            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               252

TABLE 320            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,

BY COUNTRY, 2023–2030 (USD MILLION)               252

TABLE 321            GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)                 252

TABLE 322            SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION,

2023–2030 (USD MILLION)            254

TABLE 323            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,

BY COUNTRY, 2023–2030 (USD MILLION)               254

TABLE 324            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)                 254

TABLE 325            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,

BY COUNTRY, 2023–2030 (USD MILLION)               255

TABLE 326            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,

BY COUNTRY, 2023–2030 (USD MILLION)               255

TABLE 327            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,

BY COUNTRY, 2023–2030 (USD MILLION)               256

TABLE 328            GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)                 256

TABLE 329            SINGLE-CELL ANALYSIS MARKET, BY REGION, 2023–2030 (USD MILLION)            258

TABLE 330            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            259

TABLE 331            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            260

TABLE 332            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)            260

TABLE 333            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)                 260

TABLE 334            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)            261

TABLE 335            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            261

TABLE 336            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            262

TABLE 337            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            262

TABLE 338            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 262

TABLE 339            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 263

TABLE 340            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            263

TABLE 341            NORTH AMERICA: MACROECONOMIC INDICATORS      264

TABLE 342            US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     265

TABLE 343            US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            266

TABLE 344            US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            266

TABLE 345            US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 346            US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)                267

TABLE 347            US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 268

TABLE 348            US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            268

TABLE 349            US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 268

TABLE 350            US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 269

TABLE 351            US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)                269

TABLE 352            CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            270

TABLE 353            CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            270

TABLE 354            CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            270

TABLE 355            CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            271

TABLE 356            CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            271

TABLE 357            CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)          272

TABLE 358            CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            272

TABLE 359            CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         272

TABLE 360            CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 273

TABLE 361            CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            273

TABLE 362            EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            274

TABLE 363            EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            274

TABLE 364            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            274

TABLE 365            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            275

TABLE 366            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)          275

TABLE 367            EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            275

TABLE 368            EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            276

TABLE 369            EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            276

TABLE 370            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         276

TABLE 371            EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         277

TABLE 372            EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            277

TABLE 373            EUROPE: MACROECONOMIC INDICATORS                 278

TABLE 374            GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            279

TABLE 375            GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            279

TABLE 376            GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)          279

TABLE 377            GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            280

TABLE 378            GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            280

TABLE 379            GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            281

TABLE 380            GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            281

TABLE 381            GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         281

TABLE 382            GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         282

TABLE 383            GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            282

TABLE 384            UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     283

TABLE 385            UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            283

TABLE 386            UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            283

TABLE 387            UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            284

TABLE 388            UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)                284

TABLE 389            UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 285

TABLE 390            UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            285

TABLE 391            UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         285

TABLE 392            UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)       286

TABLE 393            UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)                286

TABLE 394            FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            287

TABLE 395            FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY TYPE, 2023–2030 (USD MILLION)         287

TABLE 396            FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            287

TABLE 397            FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            288

TABLE 398            FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            288

TABLE 399            FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            289

TABLE 400            FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            289

TABLE 401            FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         289

TABLE 402            FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         290

TABLE 403            FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            290

TABLE 404            ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     291

TABLE 405            ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            291

TABLE 406            ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            291

TABLE 407            ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            292

TABLE 408            ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            292

TABLE 409            ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            293

TABLE 410            ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            293

TABLE 411            ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 293

TABLE 412            ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         294

TABLE 413            ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            294

TABLE 414            SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            295

TABLE 415            SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            295

TABLE 416            SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            295

TABLE 417            SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 418            SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            296

TABLE 419            SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            297

TABLE 420            SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            297

TABLE 421            SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         297

TABLE 422            SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         298

TABLE 423            SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            298

TABLE 424            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            299

TABLE 425            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY TYPE, 2023–2030 (USD MILLION)         299

TABLE 426            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)                 299

TABLE 427            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)            300

TABLE 428            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            300

TABLE 429            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            301

TABLE 430            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)          301

TABLE 431            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301

TABLE 432            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 302

TABLE 433            REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            302

TABLE 434            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            305

TABLE 435            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            305

TABLE 436            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)                 305

TABLE 437            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            306

TABLE 438            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)                 306

TABLE 439            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            306

TABLE 440            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            307

TABLE 441            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            307

TABLE 442            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         307

TABLE 443            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         308

TABLE 444            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            308

TABLE 445            ASIA PACIFIC: MACROECONOMIC INDICATORS                 309

TABLE 446            CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            310

TABLE 447            CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 448            CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 449            CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            311

TABLE 450            CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)          311

TABLE 451            CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            312

TABLE 452            CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            312

TABLE 453            CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         312

TABLE 454            CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         313

TABLE 455            CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            313

TABLE 456            JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            314

TABLE 457            JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            314

TABLE 458            JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            314

TABLE 459            JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            315

TABLE 460            JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            315

TABLE 461            JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            316

TABLE 462            JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            316

TABLE 463            JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 316

TABLE 464            JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 317

TABLE 465            JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            317

TABLE 466            INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     318

TABLE 467            INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 468            INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 469            INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            319

TABLE 470            INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            319

TABLE 471            INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            320

TABLE 472            INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            320

TABLE 473            INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 320

TABLE 474            INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 321

TABLE 475            INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            321

TABLE 476            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            322

TABLE 477            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)            322

TABLE 478            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            322

TABLE 479            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)            323

TABLE 480            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            323

TABLE 481            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            324

TABLE 482            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            324

TABLE 483            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 324

TABLE 484            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         325

TABLE 485            SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            325

TABLE 486            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            326

TABLE 487            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)                 326

TABLE 488            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            326

TABLE 489            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            327

TABLE 490            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            327

TABLE 491            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)          328

TABLE 492            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)          328

TABLE 493            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         328

TABLE 494            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         329

TABLE 495            AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            329

TABLE 496            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            330

TABLE 497            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY TYPE, 2023–2030 (USD MILLION)         330

TABLE 498            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,

BY TYPE, 2023–2030 (USD MILLION)         330

TABLE 499            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2030 (USD MILLION)         331

TABLE 500            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            331

TABLE 501            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            332

TABLE 502            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            332

TABLE 503            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 332

TABLE 504            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 333

TABLE 505            REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            333

TABLE 506            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            334

TABLE 507            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            334

TABLE 508            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)            334

TABLE 509            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)                 335

TABLE 510            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)            335

TABLE 511            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            335

TABLE 512            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            336

TABLE 513            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            336

TABLE 514            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 336

TABLE 515            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         337

TABLE 516            LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)          337

TABLE 517            LATIN AMERICA: MACROECONOMIC INDICATORS      338

TABLE 518            BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            338

TABLE 519            BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            339

TABLE 520            BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            339

TABLE 521            BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            340

TABLE 522            BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            340

TABLE 523            BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            341

TABLE 524            BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            341

TABLE 525            BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 341

TABLE 526            BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 342

TABLE 527            BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            342

TABLE 528            MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            343

TABLE 529            MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            343

TABLE 530            MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            343

TABLE 531            MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            344

TABLE 532            MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            344

TABLE 533            MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            345

TABLE 534            MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            345

TABLE 535            MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         345

TABLE 536            MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         346

TABLE 537            MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            346

TABLE 538            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            347

TABLE 539            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 347

TABLE 540            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,

BY TYPE, 2023–2030 (USD MILLION)         347

TABLE 541            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2030 (USD MILLION)         348

TABLE 542            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)                 348

TABLE 543            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            349

TABLE 544            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)                 349

TABLE 545            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            349

TABLE 546            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            350

TABLE 547            REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            350

TABLE 548          MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            351

TABLE 549          MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            351

TABLE 550            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)                 351

TABLE 551            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 552            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)                 352

TABLE 553          MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            352

TABLE 554          MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            353

TABLE 555          MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            353

TABLE 556            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         353

TABLE 557            MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         354

TABLE 558          MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            354

TABLE 559            MIDDLE EAST: MACROECONOMIC INDICATORS                 355

TABLE 560            GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     355

TABLE 561            GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     356

TABLE 562            GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            356

TABLE 563            GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            356

TABLE 564            GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            357

TABLE 565            GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)                357

TABLE 566            GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            358

TABLE 567            GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            358

TABLE 568            GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         358

TABLE 569            GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         359

TABLE 570            GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)                359

TABLE 571            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            360

TABLE 572            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY TYPE, 2023–2030 (USD MILLION)         360

TABLE 573            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            360

TABLE 574            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)            361

TABLE 575            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            361

TABLE 576            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            362

TABLE 577            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            362

TABLE 578            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         362

TABLE 579            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         363

TABLE 580            SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            363

TABLE 581            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            364

TABLE 582            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 364

TABLE 583            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,

BY TYPE, 2023–2030 (USD MILLION)         364

TABLE 584            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2030 (USD MILLION)         365

TABLE 585            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)          365

TABLE 586            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            366

TABLE 587            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)                 366

TABLE 588            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            366

TABLE 589            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            367

TABLE 590            UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            367

TABLE 591            REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            368

TABLE 592            REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY TYPE, 2023–2030 (USD MILLION)         368

TABLE 593            REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            368

TABLE 594            REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)                 369

TABLE 595            REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)          369

TABLE 596            REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            370

TABLE 597            REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            370

TABLE 598            REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)       370

TABLE 599            REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         371

TABLE 600            REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            371

TABLE 601            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            372

TABLE 602            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,

BY TYPE, 2023–2030 (USD MILLION)         372

TABLE 603            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,

BY TYPE, 2023–2030 (USD MILLION)         372

TABLE 604            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2030 (USD MILLION)         373

TABLE 605            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            373

TABLE 606            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            374

TABLE 607            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            374

TABLE 608            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 374

TABLE 609            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 375

TABLE 610            REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            375

TABLE 611            AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)          376

TABLE 612            AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,

2023–2030 (USD MILLION)            376

TABLE 613            AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,

2023–2030 (USD MILLION)            377

TABLE 614            AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2030 (USD MILLION)         377

TABLE 615            AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,

2023–2030 (USD MILLION)            377

TABLE 616            AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            378

TABLE 617            AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            378

TABLE 618            AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)       378

TABLE 619            AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         379

TABLE 620            AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,

2023–2030 (USD MILLION)            379

TABLE 621            MACROECONOMIC OUTLOOK FOR AFRICA                 380

TABLE 622            SINGLE-CELL ANALYSIS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025  381

TABLE 623            SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION 388

TABLE 624            SINGLE-CELL ANALYSIS MARKET: PRODUCT FOOTPRINT       392

TABLE 625            SINGLE-CELL ANALYSIS MARKET: REGION FOOTPRINT       393

TABLE 626            SINGLE-CELL ANALYSIS MARKET: TECHNIQUE FOOTPRINT       394

TABLE 627            SINGLE-CELL ANALYSIS MARKET: APPLICATION FOOTPRINT         395

TABLE 628            SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES   398

TABLE 629            SINGLE-CELL ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES                 399

TABLE 630            SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES,

JANUARY 2021–APRIL 2025            403

TABLE 631            SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2021–APRIL 2025            405

TABLE 632            SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025            407

TABLE 633            BD: COMPANY OVERVIEW           408

TABLE 634            BD: PRODUCTS OFFERED            409

TABLE 635            BD: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025           411

TABLE 636            BD: DEALS, JANUARY 2021–APRIL 2025    412

TABLE 637            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          414

TABLE 638            THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED             415

TABLE 639            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,

JANUARY 2021–APRIL 2025            418

TABLE 640            THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–APRIL 2025            418

TABLE 641            DANAHER CORPORATION: COMPANY OVERVIEW          420

TABLE 642            DANAHER CORPORATION: PRODUCTS OFFERED             421

TABLE 643            DANAHER CORPORATION: DEALS, JANUARY 2021–APRIL 2025                423

TABLE 644            10X GENOMICS: COMPANY OVERVIEW  425

TABLE 645            10X GENOMICS: PRODUCTS OFFERED   427

TABLE 646            10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            428

TABLE 647            10X GENOMICS: DEALS, JANUARY 2021–APRIL 2025        429

TABLE 648            MERCK KGAA: COMPANY OVERVIEW     431

TABLE 649            MERCK KGAA: PRODUCTS OFFERED      432

TABLE 650            MERCK KGAA: DEALS, JANUARY 2021–APRIL 2025                 434

TABLE 651            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          435

TABLE 652            AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED             436

TABLE 653            AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025   438

TABLE 654            AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–APRIL 2025            439

TABLE 655            QIAGEN: COMPANY OVERVIEW 440

TABLE 656            QIAGEN: PRODUCTS OFFERED 442

TABLE 657            QIAGEN: DEALS, JANUARY 2021–APRIL 2025                 443

TABLE 658            ILLUMINA, INC.: COMPANY OVERVIEW 444

TABLE 659            ILLUMINA, INC.: PRODUCTS OFFERED  445

TABLE 660            ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            447

TABLE 661            ILLUMINA, INC.: DEALS, JANUARY 2021–APRIL 2025        447

TABLE 662            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          449

TABLE 663            BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED             451

TABLE 664            BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025   453

TABLE 665            DIASORIN S.P.A.: COMPANY OVERVIEW 454

TABLE 666            DIASORIN S.P.A.: PRODUCTS OFFERED 456

TABLE 667            DIASORIN S.P.A.: DEALS, JANUARY 2021–APRIL 2025        456

TABLE 668            STANDARD BIOTOOLS: COMPANY OVERVIEW                 457

TABLE 669            STANDARD BIOTOOLS: PRODUCTS OFFERED                 458

TABLE 670            STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            459

TABLE 671            STANDARD BIOTOOLS: DEALS, JANUARY 2021–APRIL 2025           460

TABLE 672            TECAN TRADING AG: COMPANY OVERVIEW                 461

TABLE 673            TECAN TRADING AG: PRODUCTS OFFERED                 462

TABLE 674            TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            463

TABLE 675            TECAN TRADING AG: DEALS, JANUARY 2021–APRIL 2025           463

TABLE 676            SARTORIUS AG: COMPANY OVERVIEW  464

TABLE 677            SARTORIUS AG: PRODUCTS OFFERED   465

TABLE 678            SARTORIUS AG: DEALS, JANUARY 2021–APRIL 2025        466

TABLE 679            SARTORIUS AG: EXPANSIONS, JANUARY 2021–APRIL 2025           466

TABLE 680            CORNING INCORPORATED: COMPANY OVERVIEW          467

TABLE 681            CORNING INCORPORATED: PRODUCTS OFFERED             468

TABLE 682            CYTEK BIOSCIENCES: COMPANY OVERVIEW                 469

TABLE 683            CYTEK BIOSCIENCES: PRODUCTS OFFERED                 470

TABLE 684            CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            470

TABLE 685            CYTEK BIOSCIENCES: DEALS, JANUARY 2021–APRIL 2025           471

TABLE 686            CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021–APRIL 2025                471

TABLE 687            TAKARA BIO INC.: COMPANY OVERVIEW                 472

TABLE 688            TAKARA BIO INC.: PRODUCTS OFFERED                 473

TABLE 689            TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            475

TABLE 690            TAKARA BIO INC.: DEALS, JANUARY 2021–APRIL 2025        475

TABLE 691            BIOMÉRIEUX: COMPANY OVERVIEW      476

TABLE 692            BIOMÉRIEUX: PRODUCTS OFFERED       477

TABLE 693            BIOMÉRIEUX: DEALS, JANUARY 2021–APRIL 2025                 478

TABLE 694            REVVITY: COMPANY OVERVIEW               479

TABLE 695            REVVITY: PRODUCTS OFFERED                480

TABLE 696            REVVITY: DEALS, JANUARY 2021–APRIL 2025                 482

TABLE 697            BIO-TECHNE: COMPANY OVERVIEW      483

TABLE 698            BIO-TECHNE: PRODUCTS OFFERED       484

TABLE 699            BIO-TECHNE: DEALS      485

TABLE 700            PACBIO: COMPANY OVERVIEW 486

TABLE 701            PACBIO: PRODUCTS OFFERED  487

TABLE 702            PACBIO: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025           487

TABLE 703            BRUKER: COMPANY OVERVIEW 488

TABLE 704            BRUKER: PRODUCTS OFFERED 490

TABLE 705            BRUKER: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025           491

TABLE 706            BRUKER: DEALS, JANUARY 2021–APRIL 2025                 492

TABLE 707            PROMEGA CORPORATION: COMPANY OVERVIEW          493

TABLE 708            PROMEGA CORPORATION: PRODUCTS OFFERED             493

TABLE 709            OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW   495

TABLE 710            OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED    496

TABLE 711            OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021–APRIL 2025             497

TABLE 712            SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW          498

TABLE 713            CELL MICROSYSTEMS: COMPANY OVERVIEW                 499

TABLE 714            NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW          500

TABLE 715            RARECYTE, INC.: COMPANY OVERVIEW 501

TABLE 716            BICO: COMPANY OVERVIEW      502

TABLE 717            MENARINI GROUP: COMPANY OVERVIEW                 503

TABLE 718            APOGEE FLOW SYSTEMS LTD: COMPANY OVERVIEW          504

TABLE 719            CREATIVE BIOLABS: COMPANY OVERVIEW                 505

TABLE 720            SPHERE BIO: COMPANY OVERVIEW        506

TABLE 721            YOKOGAWA ELECTRIC CORPORATION: COMPANY OVERVIEW   507

LIST OF FIGURES

FIGURE 1              SINGLE-CELL ANALYSIS MARKET: RESEARCH DESIGN                52

FIGURE 2              BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET          54

FIGURE 3              SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024      55

FIGURE 4              MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE

ANALYSIS-BASED ESTIMATION), 2024   56

FIGURE 5              ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2024             56

FIGURE 6              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             57

FIGURE 7              MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH                58

FIGURE 8              SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS   59

FIGURE 9              DATA TRIANGULATION METHODOLOGY                 61

FIGURE 10            SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)      64

FIGURE 11           SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2025 VS. 2030 (USD MILLION)      65

FIGURE 12            SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)          65

FIGURE 13            SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)       66

FIGURE 14            SINGLE-CELL ANALYSIS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      66

FIGURE 15            GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET          67

FIGURE 16            GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET               68

FIGURE 17            HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2024                69

FIGURE 18            CONSUMABLES SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2025               69

FIGURE 19            ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD                70

FIGURE 20            ASIA PACIFIC COUNTRIES TO REGISTER FASTEST GROWTH

DURING FORECAST PERIOD       70

FIGURE 21            SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     71

FIGURE 22            AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER

INCIDENCES IN MEN AND WOMEN, 2022                74

FIGURE 23            WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014–2028              75

FIGURE 24            SHARE OF PERSONALIZED MEDICINE IN FDA’S NEW DRUG APPROVALS,

2015–2023              79

FIGURE 25            TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS   83

FIGURE 26            SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS            84

FIGURE 27            SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS            85

FIGURE 28            PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET, JANUARY 2014–DECEMBER 2024        93

FIGURE 29            SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 99

FIGURE 30            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF

SINGLE-CELL ANALYSIS PRODUCTS       110

FIGURE 31            KEY BUYING CRITERIA FOR END USERS                 111

FIGURE 32            SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,

2023–2030 (THOUSAND UNITS)  210

FIGURE 33            NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT       259

FIGURE 34            NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025        265

FIGURE 35            ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT          304

FIGURE 36            REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET,

2022–2024              386

FIGURE 37            MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024        387

FIGURE 38            RANKING OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2024               389

FIGURE 39            SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2024     390

FIGURE 40            SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT       391

FIGURE 41            SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023                 397

FIGURE 42            EV/EBITDA OF KEY VENDORS   400

FIGURE 43            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                400

FIGURE 44            SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     401

FIGURE 45            BD: COMPANY SNAPSHOT (2024)              409

FIGURE 46            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             415

FIGURE 47            DANAHER CORPORATION: COMPANY SNAPSHOT (2024)             421

FIGURE 48            10X GENOMICS: COMPANY SNAPSHOT (2024)                 426

FIGURE 49            MERCK KGAA: COMPANY SNAPSHOT (2024)                 432

FIGURE 50            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)             436

FIGURE 51            QIAGEN: COMPANY SNAPSHOT (2024)   441

FIGURE 52            ILLUMINA, INC.: COMPANY SNAPSHOT (2024)                 445

FIGURE 53            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             450

FIGURE 54            DIASORIN S.P.A.: COMPANY SNAPSHOT (2024)                 455

FIGURE 55            STANDARD BIOTOOLS: COMPANY SNAPSHOT (2024)    458

FIGURE 56            TECAN TRADING AG: COMPANY SNAPSHOT (2024)    462

FIGURE 57            SARTORIUS AG: COMPANY SNAPSHOT (2024)                 465

FIGURE 58            CORNING INCORPORATED: COMPANY SNAPSHOT (2024)             468

FIGURE 59            CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)    469

FIGURE 60            TAKARA BIO INC.: COMPANY SNAPSHOT (2023)                 473

FIGURE 61            BIOMÉRIEUX: COMPANY SNAPSHOT (2024)                 477

FIGURE 62            REVVITY: COMPANY SNAPSHOT (2024)  480

FIGURE 63            BIO-TECHNE: COMPANY SNAPSHOT (2023)                 484

FIGURE 64            PACBIO: COMPANY SNAPSHOT (2024)    486

FIGURE 65            BRUKER: COMPANY SNAPSHOT (2024)   489

FIGURE 66            OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024)      495

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧